431 related articles for article (PubMed ID: 32507359)
1. Adrenocortical tumorigenesis: Lessons from genetics.
Kamilaris CDC; Hannah-Shmouni F; Stratakis CA
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101428. PubMed ID: 32507359
[TBL] [Abstract][Full Text] [Related]
2. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
[TBL] [Abstract][Full Text] [Related]
3. Genetic Alterations in Benign Adrenal Tumors.
Pitsava G; Stratakis CA
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625779
[TBL] [Abstract][Full Text] [Related]
4. Genetic background of adrenocortical tumor development.
Kjellman M; Larsson C; Bäckdahl M
World J Surg; 2001 Jul; 25(7):948-56. PubMed ID: 11572037
[TBL] [Abstract][Full Text] [Related]
5. The genetics of adrenocortical tumors.
Espiard S; Bertherat J
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
[TBL] [Abstract][Full Text] [Related]
6. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
Almeida MQ; Stratakis CA
Mol Cell Endocrinol; 2011 Apr; 336(1-2):162-8. PubMed ID: 21111774
[TBL] [Abstract][Full Text] [Related]
7. Genomics of benign adrenocortical tumors.
Jouinot A; Armignacco R; Assié G
J Steroid Biochem Mol Biol; 2019 Oct; 193():105414. PubMed ID: 31207362
[TBL] [Abstract][Full Text] [Related]
8. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
9. 5th International ACC Symposium: The New Genetics of Benign Adrenocortical Neoplasia: Hyperplasias, Adenomas, and Their Implications for Progression into Cancer.
Kirschner LS; Stratakis CA
Horm Cancer; 2016 Feb; 7(1):9-16. PubMed ID: 26684645
[TBL] [Abstract][Full Text] [Related]
10. The Many Faces of Primary Aldosteronism and Cushing Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity.
Mete O; Duan K
Front Med (Lausanne); 2018; 5():54. PubMed ID: 29594118
[TBL] [Abstract][Full Text] [Related]
11. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
[TBL] [Abstract][Full Text] [Related]
12. Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome.
Vaduva P; Bonnet F; Bertherat J
J Endocr Soc; 2020 Sep; 4(9):bvaa075. PubMed ID: 32783015
[TBL] [Abstract][Full Text] [Related]
13. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
14. Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).
Stratakis CA
Endocr Dev; 2008; 13():117-132. PubMed ID: 18493137
[TBL] [Abstract][Full Text] [Related]
15. Genetics of primary hyperaldosteronism.
Dutta RK; Söderkvist P; Gimm O
Endocr Relat Cancer; 2016 Oct; 23(10):R437-54. PubMed ID: 27485459
[TBL] [Abstract][Full Text] [Related]
16. Genetic Characterization of GnRH/LH-Responsive Primary Aldosteronism.
Gagnon N; Cáceres-Gorriti KY; Corbeil G; El Ghoyareb N; Ludwig N; Latour M; Lacroix A; Bourdeau I
J Clin Endocrinol Metab; 2018 Aug; 103(8):2926-2935. PubMed ID: 29726953
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.
Hsiao HP; Kirschner LS; Bourdeau I; Keil MF; Boikos SA; Verma S; Robinson-White AJ; Nesterova M; Lacroix A; Stratakis CA
J Clin Endocrinol Metab; 2009 Aug; 94(8):2930-7. PubMed ID: 19509103
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases.
Libé R; Bertherat J
Eur J Endocrinol; 2005 Oct; 153(4):477-87. PubMed ID: 16189167
[TBL] [Abstract][Full Text] [Related]
19. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms.
Gicquel C; Bertherat J; Le Bouc Y; Bertagna X
Endocrinol Metab Clin North Am; 2000 Mar; 29(1):1-13, vii. PubMed ID: 10732260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
